Pulpyvax®

For the active immunisation of sheep and goats against pulpy kidney disease (enterotoxaemia).

FOR ANIMAL USE ONLY

PULPYVAX®

Reg. No. G2192 (Act 36/1947)

Namibia Reg. No. V96/24.4/502 [NS0]

INDICATIONS

For the active immunisation of sheep and goats against pulpy kidney disease (enterotoxaemia).

COMPOSITION

Alum-precipitated Clostridium perfringens type D toxoids.

STORAGE INSTRUCTIONS

  • Store between 2 ºC and 8 ºC.
  • Do not freeze.
  • Protect from light.

WARNINGS

  • Withdrawal period: Do not slaughter animals for human consumption within 21 days after vaccination.
  • Vaccinate healthy animals only.
  • Usually no marked reaction follows vaccination, although a transient swelling may appear at the site of inoculation, and some animals may show a moderate rise in temperature for one or two days.
  • Do not over- or under-dose the vaccine.
  • Do not mix this vaccine with any other vaccine or medication.
  • In case of accidental self-injection, seek medical advice immediately and show the package insert to the physician.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Observe aseptic precautions. Ensure that all vaccination equipment (containers, syringes and needles) is clean and sterile prior to and during use. Use sterile equipment when administering the vaccine.
  • Do not use disinfectants or antiseptics to sterilise any equipment.
  • It is good vaccination practice when handling the vaccine to avoid contact with the eyes, hands and clothing.
  • Adhere to the vaccination programme to obtain optimum results.
  • Do not eat, drink or smoke whilst handling the product.
  • Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).
  • Do not contaminate rivers, dams or any water sources with containers or waste.        

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

  • Shake bottle well before use and from time to time during the vaccination process.
  • If possible, use a separate, sharp, sterile needle for each animal.
  • Administer Pulpyvax® subcutaneously on the side of the neck, midway between the shoulder and the head of sheep.
  • Goats should be vaccinated under the loose skin underneath the tail. Do not vaccinate goats in the neck.
  • Sheep and goats not previously vaccinated, should be given 2 injections of vaccine, with an interval of 4 to 6 weeks.
  • Lambs and kids can be immunised from 3 months of age. Administer a second dose, 4 to 6 weeks later.
  • An annual booster injection should be given to the whole flock 2 to 6 weeks before the ewes are due to lamb.
  • Lambs born from ewes vaccinated before lambing are protected for 12 to 16 weeks by the antibodies passed in the colostrum.
  • It is sound practice to re-inoculate vaccinated sheep shortly before the period of greatest risk.

Note: Lambs and kids younger than 2 months and animals in poor condition, infested with parasites or that are suffering from other diseases will not immunise well.

DOSAGE

Sheep and goats of all ages: Inject 1 mℓ subcutaneously.

PRESENTATION

Off-white suspension containing formalinised, alum-precipitated Clostridium perfringens type D (epsilon) toxoids.

100 mℓ (100 doses) multi-dose vials.

250 mℓ (250 doses) multi-dose vials.

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

MANUFACTURER

Prondil S.A.

Barros Arana 5402,

Montevideo, Uruguay

DATE OF PUBLICATION OF THIS PACKAGE INSERT

30 June 2017